Research and Treatment
TREAT Asia and its network of researchers, HIV clinics, and other partner institutions are working to understand optimal approaches to treating HIV, common co-infections, and comorbid conditions among adults and children, particularly in resource-limited settings. The TREAT Asia network currently includes 21 adult and 21 pediatric clinical sites and orphan support programs in 12 countries, which contribute to a number of research activities and studies.
In 2006, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) selected TREAT Asia and the Kirby Institute to co-lead the Asia-Pacific component of its global HIV database consortium known as the International epidemiology Databases to Evaluate AIDS (IeDEA). This work has continued since that time, allowing the network to expand its research portfolio and contribute to improved care and better quality of life for people living with HIV in the Asia-Pacific region.
Adult HIV Research
TREAT Asia’s network of researchers study multiple aspects of HIV treatment of adults living with HIV in the region. This includes HIV clinical outcomes, antiretroviral treatment outcomes, and co-infections and comorbidities.
Child and Adolescent HIV Research
TREAT Asia network research studies children and adolescents who have grown up living with HIV as well as young adults who have acquired HIV later in their lives. Research priorities include HIV prevention, clinical and treatment outcomes, coinfections, comorbidities, and the transition from pediatric to adult HIV care.
HIV and Co-infection Research
HIV is often associated with a number of other infections that include hepatitis B, hepatitis C, tuberculosis, and human papillomavirus. TREAT Asia studies how these co-infections affect or are influenced by HIV infection and how they can best be treated.
HIV and Comorbidity Research
As HIV treatment programs become more successful and engage more individuals in care, people living with HIV are increasingly affected by conditions such as cardiovascular disease, neurocognitive decline, and mental health issues. TREAT Asia investigators study the links between HIV and these conditions, and regional capacities to manage them.
HIV and Cancer
People living with HIV are often at greater risk for certain cancers, including anal, cervical and liver cancer. TREAT Asia studies risk factors and associated outcomes for these cancers, including other viral infections such as hepatitis C, and behavioral risks such as tobacco and alcohol use.
TREAT Asia Community Advisory Group (CAG)
Members provide guidance to TREAT Asia’s research activities across the Asia-Pacific region.
